Jazz Pharmaceuticals plc Decrease in Unrecognized Tax Benefits is Reasonably Possible
Jazz Pharmaceuticals plc (JAZZ) had Decrease in Unrecognized Tax Benefits is Reasonably Possible of $26.70 million as of 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible · last filed 2025-02-26
- 2024-12-31: Decrease in Unrecognized Tax Benefits is Reasonably Possible $26.70M.
- 2023-12-31: Decrease in Unrecognized Tax Benefits is Reasonably Possible $26.50M.
| Period end | Decrease in Unrecognized Tax Benefits is Reasonably Possible |
|---|---|
| 2024-12-31 | $26.70M 10-K · filed 2025-02-26 |
| 2023-12-31 | $26.50M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |